Counterparts in each pair were matched for age, gender, diagnosis, stage of disease, and previous chemotherapy exposure
Data availability All data supporting the findings of this study are included in this published article and its Supplementary Information files, and are available from the corresponding author upon request
In contrast, Wegovy, containing the same active ingredient semaglutide, was developed specifically for weight loss and is approved solely for that purpose
NAD infusions are designed for a slower, more gradual drip experience, with supervision and support throughout the appointment
Our team submits and manages this process on your behalf, which is often the deciding factor in whether coverage is approved
Yes, significant weight loss from semaglutide may decrease your levothyroxine requirements